Denka Company Limited manufactures and sells organic and inorganic materials to electronic materials and pharmaceuticals in Japan and internationally. The company's Electronics & Innovative Products division provides conductive agents for lithium for lithium-ion batteries, thermal materials and substrates, functional ceramics, films, and tapes. Its Life Innovation division supplies influenza vaccines; manufactures rapid diagnostic testing kits for detecting antigens of infectious diseases, such as the novel coronavirus; and delivers macromolecular sodium hyaluronate preparations. The company's Elastomers & Infrastructure Solutions division include functional elastomers, cement and special cement additives, fertilizers, agricultural corrugated pipes. Its Polymer Solutions division consist of styrene-based resins, food packaging sheets, and synthetic fiber for wigs and hairpieces, as well as poval and other chemical products. The company was formerly known as Denki Kagaku Kogyo Kabushiki Kaisha and changed its name to Denka Company Limited in October 2015. Denka Company Limited was incorporated in 1915 and is headquartered in Tokyo, Japan.

Denka Company Limited

Denka is involved in manufacturing and selling a variety of products, including chemicals, electronics, and materials, and is self-described as a leading provider in multiple sectors.

Denka

Denka Company Limited | 1,703 followers on LinkedIn. Denka Company Limited (Denka) was established in 1915 for the production of calcium carbide and chemical fertilizers by utilizing abundant limestone resources and its in-house electric power plants. Since then, we have grown to become a unique chemicals manufacturer involved in the production and distribution of a wide range of chemical products from inorganic and organic materials to electronic materials and processed resin products. These materials are based on our proprietary technologies of electric furnace controls, high-temperature reaction controls, organic synthesis and others nurtured over long years of experience in the field of calcium carbide chemicals business.

	Dec '13	Mar '14	Jun '14	Sep '14	Dec '14	Mar '15	Jun '15	Sep '15	Dec '15	Mar '16	Jun '16	Sep '16	Dec '16	Mar '17	Jun '17	Sep '17	Dec '17	Mar '18	Jun '18	Sep '18	Dec '18	Mar '19	Jun '19	Sep '19	Dec '19	Mar '20	Jun '20	Sep '20	Dec '20	Mar '21	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22	Sep '22	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	Jun '24
net income	3.98B -	2.14B 46.08%	2.02B 5.55%	5.50B 171.51%	6.33B 15.13%	5.17B 18.36%	4.37B 15.52%	5.52B 26.41%	5.98B 8.33%	3.61B 39.66%	2.23B 38.14%	3.88B 73.92%	7.44B 91.65%	4.59B 38.29%	6.04B 31.63%	6.23B 3.13%	6.67B 7.06%	4.09B 38.73%	6.23B 52.35%	5.16B 17.12%	7.03B 36.23%	6.62B 5.80%	5.02B 24.25%	5.83B 16.26%	5.85B 0.24%	6.00B 2.65%	4.19B 30.20%	5.82B 38.85%	8.88B 52.66%	3.90B 56.15%	6.16B 58.05%	11.89B 93.13%	4.87B 59.07%	3.10B 36.27%	4.34B 39.86%	9.99B 130.34%	-5.49B 154.90%	3.93B 171.58%	2.29B 41.54%	4.26B 85.80%	-2.98B 169.82%	8.37B 380.99%	2.25B 73.10%
depreciation and amortization																																				6.80B -	6.79B 0.07%	6.88B 1.35%	6.69B 2.86%	6.73B 0.66%	6.73B 0%
deferred income tax
stock based compensation
change in working capital
accounts receivables
inventory
accounts payables
other working capital
other non cash items	-3.98B -	-2.14B 46.08%	-2.02B 5.55%	-5.50B 171.51%	-6.33B 15.13%	-5.17B 18.36%	-4.37B 15.52%	-5.52B 26.41%	-5.98B 8.33%	-3.61B 39.66%	-2.23B 38.14%	-3.88B 73.92%	-7.44B 91.65%	-4.59B 38.29%	-6.04B 31.63%	-6.23B 3.13%	-6.67B 7.06%	-4.09B 38.73%	-6.23B 52.35%	-5.16B 17.12%	-7.03B 36.23%	-6.62B 5.80%	-5.02B 24.25%	-5.83B 16.26%	-5.85B 0.24%	-6.00B 2.65%	-4.19B 30.20%	-5.82B 38.85%	-8.88B 52.66%	-3.90B 56.15%	-6.16B 58.05%	-11.89B 93.13%	-4.87B 59.07%	-3.10B 36.27%	-4.34B 39.86%	-3.19B 26.38%	12.28B 484.50%	2.96B 75.91%	4.39B 48.48%	2.47B 43.83%	9.71B 293.51%	-8.37B 186.17%	-2.25B 73.10%
net cash provided by operating activities																																				13.59B -	13.58B 0.07%	13.77B 1.35%	13.37B 2.86%	13.46B 0.66%	13.46B 0%
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
debt repayment
common stock issued
common stock repurchased
dividends paid
other financing activites
net cash used provided by financing activities
effect of forex changes on cash
net change in cash																																				-868M -	-193M 77.76%	-2.05B 964.25%	2.15B 204.72%	-1.94B 190.19%	10.96B 664.95%
cash at beginning of period																																				23.31B -	22.45B 3.72%	22.25B 0.86%	20.20B 9.23%	22.35B 10.65%	20.41B 8.68%
cash at end of period																																				22.45B -	22.25B 0.86%	20.20B 9.23%	22.35B 10.65%	20.41B 8.68%	31.37B 53.70%
operating cash flow																																				13.59B -	13.58B 0.07%	13.77B 1.35%	13.37B 2.86%	13.46B 0.66%	13.46B 0%
capital expenditure
free cash flow																																				13.59B -	13.58B 0.07%	13.77B 1.35%	13.37B 2.86%	13.46B 0.66%	13.46B 0%

4061

JP:CO:DENKA

Denka

Last Close

2,131.00

25/11 06:45

Market Cap

186.75B

Beta: -

Volume Today

388.50K

Avg: -

Preview